Ziopharm Oncology buy exploration
Start price
22.04.16
/
50%
€7.12
Target price
19.07.16
€10.10
Performance (%)
-43.45%
End price
19.07.16
€4.03
Summary
This prediction ended on 19.07.16 with a price of €4.03. Massive losses of -43.45% were the result for the BUY prediction by exploration. exploration has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ziopharm Oncology | - | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% | 68.786% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% | 100.066% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% | 43.024% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% | 63.222% |
Comments by exploration for this prediction
In the thread Ziopharm Oncology diskutieren
Ziopharm: Biotechwerte werden wieder interessant
langfristig werden auch Biotechwerte wieder interessant.
(Stop Loss Kurs erreicht)


